产品介绍:
产品说明
包装
5, 25 mg in glass bottle
生化/生理作用
MDL 11,939 is a potent, selective and orally active 5-HT2 receptor antagonist (ASTAR). Ki values values are in the low nanomolar range for 5-HT2A with over 100-fold selectivity over 5-HT2C receptors and low or no affinity for non-5-HT2 receptors or transporters.
特点和优势
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
基本信息
经验(实验)分子式 | C20H25NO |
分子量 | 295.42 |
MDL编号 | MFCD00864701 |
PubChem化学物质编号 | 329825167 |
NACRES | NA.77 |
产品性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | powder |
颜色 | white to tan |
溶解性 | DMSO: ≥8 mg/mL |
创始人 | Sanofi Aventis |
储存温度 | 2-8℃ |
SMILES string | OC(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3 |
InChI | 1S/C21H27NO/c23-21(19-11-5-2-6-12-19)20-13-16-22(17-14-20)15-7-10-18-8-3-1-4-9-18/h1-6,8-9,11-12,20-21,23H,7,10,13-17H2 |
InChI key | CTDVLAJTGZQELM-UHFFFAOYSA-N |
安全信息
象形图 | |
警示用语: | Warning |
危险声明 | H400 |
预防措施声明 | P273 |
危险分类 | Aquatic Acute 1 |
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |